Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

TET2 Knockout K-562 Cell Line

The TET2 Knockout K-562 Cell Line is a CRISPR/Cas9-edited knockout model in BCR-ABL-positive K-562 chronic myeloid leukemia cells, enabling loss-of-function studies of the TET2 dioxygenase…
Cat. No. ARG44151

TEAD1 Knockout BEAS-2B Cell Line

The TEAD1 Knockout BEAS-2B Cell Line is a CRISPR/Cas9-edited knockout cell line derived from human bronchial epithelial BEAS-2B cells, featuring targeted disruption of the Hippo…
Cat. No. ARG44150

Tbx15 Knockout THP-1 Cell Line

The Tbx15 Knockout THP-1 Cell Line is a CRISPR/Cas9-edited THP-1 human acute monocytic leukemia cell line with targeted disruption of the TBX15 gene. TBX15 encodes…
Cat. No. ARG44149

Tbx15 Knockout ST2 Cell Line

The Tbx15 Knockout ST2 Cell Line is a CRISPR/Cas9-edited mouse bone marrow stromal cell line with targeted disruption of Tbx15, a T-box transcription factor that…
Cat. No. ARG44148

TAB1 Knockout A2780 Cell Line

The TAB1 Knockout A2780 Cell Line is a CRISPR/Cas9-edited human ovarian adenocarcinoma cell model with targeted disruption of the TAB1 gene. TAB1 serves as an…
Cat. No. ARG44147

Sucla2 Knockout NIH 3T3 Cell Line

The Sucla2 Knockout NIH 3T3 Cell Line is a CRISPR/Cas9-edited knockout cell line designed to disrupt the Sucla2 gene, encoding the beta subunit of succinyl-CoA…
Cat. No. ARG44146

STUB1 Knockout HEK293T Cell Line

The STUB1 Knockout HEK293T Cell Line is a CRISPR/Cas9-edited knockout cell line in which the STUB1 gene has been disrupted in HEK293T cells. STUB1 encodes…
Cat. No. ARG44145

Stub1 Knockout RCS Cell Line

The Stub1 Knockout RCS Cell Line provides a CRISPR/Cas9-edited loss-of-function model in rat chondrosarcoma cells, targeting STUB1 (CHIP), an E3 ubiquitin ligase that functions as…
Cat. No. ARG44144

STON2 Knockout 6-10B Cell Line

The STON2 Knockout 6-10B Cell Line is a CRISPR/Cas9-edited gastric adenocarcinoma cell model with targeted disruption of the STON2 gene, resulting in loss of stonin-2…
Cat. No. ARG44143

Stk36 Knockout Neuro-2a Cell Line

The Stk36 Knockout Neuro-2a Cell Line is a CRISPR/Cas9-edited knockout cell line with targeted disruption of the mouse Stk36 gene in Neuro-2a neuroblastoma cells. STK36…
Cat. No. ARG44142

Sting1 Knockout BV-2 Cell Line

The Sting1 Knockout BV-2 Cell Line is a CRISPR/Cas9-edited murine microglial cell line with targeted disruption of the Sting1 gene, abolishing expression of the STING…
Cat. No. ARG44141

STING1 Knockout HK-2 Cell Line

The STING1 Knockout HK-2 Cell Line is a CRISPR/Cas9-edited human proximal tubule epithelial cell line with targeted disruption of the STING1 (TMEM173) gene. This loss-of-function…
Cat. No. ARG44140

Loading products...